Explore

Trendline Trendline
Soligenix Reports First Quarter 2026 Financial Results Amid Clinical Trial Challenges

Soligenix Reports First Quarter 2026 Financial Results Amid Clinical Trial Challenges

Soligenix Reports First Quarter 2026 Financial Results Amid Clinical Trial Challenges
Trendline Trendline
Soligenix Reports Financial Results and Strategic Updates Amid Clinical Trial Challenges

Soligenix Reports Financial Results and Strategic Updates Amid Clinical Trial Challenges

Soligenix Reports Financial Results and Strategic Updates Amid Clinical Trial Challenges
Trendline Trendline
Soligenix Reports Financial Results and Updates on Rare Disease Treatments

Soligenix Reports Financial Results and Updates on Rare Disease Treatments

Soligenix Reports Financial Results and Updates on Rare Disease Treatments
Trendline Trendline
BioLife Solutions Reports 25% Revenue Growth in Q1 2026, Driven by Cell and Gene Therapy Market

BioLife Solutions Reports 25% Revenue Growth in Q1 2026, Driven by Cell and Gene Therapy Market

BioLife Solutions Reports 25% Revenue Growth in Q1 2026, Driven by Cell and Gene Therapy Market
Trendline Trendline
Atossa Therapeutics Reports Q1 2026 Financial Results and Strategic Developments

Atossa Therapeutics Reports Q1 2026 Financial Results and Strategic Developments

Atossa Therapeutics Reports Q1 2026 Financial Results and Strategic Developments
Trendline Trendline
Arrowhead Pharmaceuticals Reports Strong Fiscal 2026 Second Quarter Results Amidst Growth Initiatives

Arrowhead Pharmaceuticals Reports Strong Fiscal 2026 Second Quarter Results Amidst Growth Initiatives

Arrowhead Pharmaceuticals Reports Strong Fiscal 2026 Second Quarter Results Amidst Growth Initiatives
Trendline Trendline
Arrowhead Pharmaceuticals Reports Strong Q2 2026 Financial Results

Arrowhead Pharmaceuticals Reports Strong Q2 2026 Financial Results

Arrowhead Pharmaceuticals Reports Strong Q2 2026 Financial Results
Trendline Trendline
Zura Bio Reports Strong Financial Position and Progress in Clinical Trials

Zura Bio Reports Strong Financial Position and Progress in Clinical Trials

Zura Bio Reports Strong Financial Position and Progress in Clinical Trials
Trendline Trendline
Rocket Pharmaceuticals Reports Financial Results and Progress in Gene Therapy Pipeline

Rocket Pharmaceuticals Reports Financial Results and Progress in Gene Therapy Pipeline

Rocket Pharmaceuticals Reports Financial Results and Progress in Gene Therapy Pipeline
Trendline Trendline
Puma Biotechnology Raises 2026 Revenue Guidance Amid NERLYNX Demand

Puma Biotechnology Raises 2026 Revenue Guidance Amid NERLYNX Demand

Puma Biotechnology Raises 2026 Revenue Guidance Amid NERLYNX Demand
Trendline Trendline
Stoke Therapeutics Reports Q1 2026 Financial Results and Advances Dravet Syndrome Treatment

Stoke Therapeutics Reports Q1 2026 Financial Results and Advances Dravet Syndrome Treatment

Stoke Therapeutics Reports Q1 2026 Financial Results and Advances Dravet Syndrome Treatment
Trendline Trendline
Rocket Pharmaceuticals Advances Gene Therapy Pipeline with FDA Engagement and Financial Strength

Rocket Pharmaceuticals Advances Gene Therapy Pipeline with FDA Engagement and Financial Strength

Rocket Pharmaceuticals Advances Gene Therapy Pipeline with FDA Engagement and Financial Strength